ANBT
CRL icon

American National Bank & Trust’s Charles River Laboratories CRL Stock Holding History

American National Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$6.4K – 490
2024
Q2 		$6.4K Buy
+31
New +$7.02K ﹤0.01% 480

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

American National Bank & Trust's CRL Position: Q3 2024 in Review

American National Bank & Trust sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 31 shares — an estimated $6.4K sold.

American National Bank & Trust first reported a position in CRL in Q2 2024 and held it in 1 quarter. The position peaked at $6.4K in Q2 2024. 627 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • American National Bank & Trust reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • American National Bank & Trust sold 31 Charles River Laboratories shares in Q3 2024, an estimated $6.4K.
  • American National Bank & Trust first reported a position in Charles River Laboratories in Q2 2024 and held it in 1 quarter.
  • American National Bank & Trust's Charles River Laboratories position peaked at $6.4K in Q2 2024.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on American National Bank & Trust's 13F filing for Q3 2024, filed 2 Oct 2024.